03:47 AM EST, 12/16/2024 (MT Newswires) -- Justin Chakma, Chief Business Officer, on December 12, 2024, sold 144,605 shares in ARS Pharmaceuticals ( SPRY ) for $1,768,093. Following the Form 4 filing with the SEC, Chakma has control over a total of 136,380 shares of the company, with 136,380 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1671858/000141588924029377/xslF345X05/form4-12142024_121217.xml